Brain fluorodeoxyglucose PET in adrenoleukodystrophy

Neurology

Volumn 83, Issue 11, 2014, Pages 981-989

  Salsano, Ettore ^a   Marotta, Giorgio ^b   Manfredi, Valentina ^a   Giovagnoli, Anna Rita ^a   Farina, Laura ^a   Savoiardo, Mario ^a   Pareyson, Davide ^a   Benti, Riccardo ^b   Uziel, Graziella ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; BRAIN METABOLISM; CEREBELLUM; CLINICAL ARTICLE; COGNITION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY ASSESSMENT; FRONTAL LOBE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; IMAGING SOFTWARE; MALE; MENTAL DISEASE; MILLON CLINICAL MULTIAXIAL INVENTORY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; PARAMETRIC TEST; PERSONALITY; PET-CT SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYMPTOM CHECKLIST 90; WHITE MATTER LESION; YOUNG ADULT; BRAIN; BRAIN MAPPING; COMPUTER PROGRAM; CROSS-SECTIONAL STUDY; IMAGE PROCESSING; METABOLISM; METHODOLOGY; MIDDLE AGED; PERSONALITY TEST; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; SCINTISCANNING;

ADRENOLEUKODYSTROPHY; ADULT; BRAIN; BRAIN MAPPING; CROSS-SECTIONAL STUDIES; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PERSONALITY; PERSONALITY ASSESSMENT; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS; SOFTWARE; YOUNG ADULT;

EID: 84908301459     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000770     Document Type: Article

References (34)

1. Semmler A, Köhler W, Jung HH, Weller M, Linnebank M. Therapy of X-linked adrenoleukodystrophy. Expert Rev Neurother 2008;8:1367-1379.
2. Dobyns WB, Filauro A, Tomson BN, et al. Inheritance of most X-linked traits is not dominant or recessive, just Xlinked. Am J Med Genet A 2004;129A:136-143.
3. Singh I, Pujol A. Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol 2010; 20:838-844.
4. Koehler W, Sokolowski P. A new disease-specific scoring system for adult phenotypes of X-linked adrenoleukodystrophy. J Mol Neurosci 1999;13:247-252.
5. Volkow ND, Patchell L, Kulkarni MV, Reed K, Simmons M. Adrenoleukodystrophy: imaging with CT, MRI, and PET. J Nucl Med 1987;28:524-527.
6. Iinuma K, Haginoya K, Handa I, et al. Computed tomography, magnetic resonance imaging, positron emission tomography and evoked potentials at early stage of adrenoleukodystrophy. Tohoku J Exp Med 1989;159:195-203.
7. Bakheet S, Al-Essa M, Patay Z, et al. Cerebral fluorine-18 fluorodeoxyglucose positron emission tomographic findings in X-linked adrenoleukodystrophy. Clin Nucl Med 1999;24:364-365.
8. Renard D, Castelnovo G, Collombier L, Kotzki PO, Labauge P. Brain fludeoxyglucose F 18 positron emission tomography hypometabolism in magnetic resonance imaging-negative X-linked adrenoleukodystrophy. Arch Neurol 2011;68:1338-1339.
9. Kim JE, Choi KG, Jeong JH, Kang HJ, Kim HS. Diffuse cortical hypometabolism on (18)F-FDG-PET scan in a case of an adult variant cerebello-brainstem dominant form of ALD manifesting dementia. Parkinsonism Relat Disord 2012;18:210-212.
10. Loes DJ, Fatemi A, Melhem ER, et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 2003;61:369-374.
11. Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 1987;6:1-120.
12. Orsini A, Grossi D, Capitani E, Laiacona M, Papagno C, Vallar G. Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. Ital J Neurol Sci 1987;8:539-548.
13. Novelli G, Papagno C, Capitani E, Laiacona M, Vallar G, Cappa SF. Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Arch Psicol Neurol Psichiatr 1986;47:447-506.
14. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci 2002;22: 443-447.
15. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E. Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci 1996;17:305-309.
16. Basso A, Capitani E, Laiacona M. Raven's coloured progressive matrices: normative data on 305 adult normal controls. Funct Neurol 1987;2:189-194.
17. Derogatis LR. Administration, Scoring, and Procedures Manual for the SCL-90-R. Baltimore, MD: Clinical Psychometrics Research; 1977.
18. Millon T, Davis R. MCMI-III: Millon Clinical Multiaxial Inventory-III Manual. Minneapolis, MN: National Computer Systems; 2006.
19. Kumar A, Newberg A, Alavi A, Berlin J, Smith R, Reivich M. Regional cerebral glucose metabolism in latelife depression and Alzheimer disease: a preliminary positron emission tomography study. Proc Natl Acad Sci U S A 1993;90:7019-7023.
20. Kumar A, Chugani HT, Chakraborty P, Huq AH. Evaluation of neuroinflammation in X-linked adrenoleukodystrophy. Pediatr Neurol 2011;44:143-146.
21. Powers JM. Adreno-leukodystrophy (adreno-testiculoleukomyelo-neuropathic-complex). Clin Neuropathol 1985;4:181-199.
22. Ferrer I, Aubourg P, Pujol A. General aspects and neuropathology of X-linked adrenoleukodystrophy. Brain Pathol 2010;20:817-830.
23. Iglesias S, Marchal G, Viader F, Baron JC. Delayed intrahemispheric remote hypometabolism. Correlations with early recovery after stroke. Cerebrovasc Dis 2000;10: 391-402.
24. Selwyn R, Hokenbury N, Jaiswal S, Mathur S, Armstrong RC, Byrnes K. Mild traumatic brain injury results in depressed cerebral glucose uptake: an 18FDG PET Study. J Neurotrauma 2013;23:1943-1953.
25. Powers JM, DeCiero DP, Ito M, Moser AB, Moser HW. Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol 2000;59:89-102.
26. Morbelli S, Perneczky R, Drzezga A, et al. Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project. J Nucl Med 2013;54:894-902.
27. Edwin D, Speedie LJ, Kohler W, Naidu S, Kruse B, Moser HW. Cognitive and brain magnetic resonance imaging findings in adrenomyeloneuropathy. Ann Neurol 1996;40:675-678.
28. Salsano E, Gambini O, Giovagnoli AR, Farina L, Uziel G, Pareyson D. Effectiveness of valproate for the treatment of manic-like behavior in X-linked adrenoleukodystrophy. Neurol Sci 2012;33:1197-1199.
29. Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2004;65: 948-958.
30. Cilia R, Siri C, Marotta G, et al. Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol 2008;65:1604-1611.
31. Horn MA, Nilsen KB, Jørum E,Mellgren SI, Tallaksen CM. Small nerve fiber involvement is frequent in X-linked adrenoleukodystrophy. Neurology 2014;82:1678-1683.
32. Hauser SL, Dawson DM, Lehrich JR, et al. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 1983;308:173-180.
33. Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;192:540-542.
34. van Geel BM, Koelman JH, Barth PG, Ongerboer de Visser BW. Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study. Neurology 1996;46:112-118.